Cite
HARVARD Citation
Patoulias, D. et al. (n.d.). Sodium-glucose co-transporter-2 inhibitors improve cardiovascular outcomes in heart failure with reduced ejection fraction regardless of ischemic etiology. European heart journal. p. . [Online].